LC3 deacetylation by SIRT1 is involved in neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's disease

被引：0
|
作者：
Wu, Y.
Guo, Y.
Dong, S.
Cui, X.
Feng, Y.
Zhao, W.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
781
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [41] Neuroprotective Effects of Cuscutae Semen in a Mouse Model of Parkinson's Disease
    Ye, Minsook
    Lee, Seul Gi
    Chung, Eun Sook
    Lim, Su-jin
    Kim, Won Seob
    Yoon, Heera
    Kim, Sun Kwang
    Ahn, Kwang Sung
    Jang, Young Pyo
    Bae, Hyunsu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [42] Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β Pathway
    Zhang, Wei
    He, Hong
    Song, Hujie
    Zhao, Junjie
    Li, Tao
    Wu, Leitao
    Zhang, Xiaojun
    Chen, Jianzong
    PARKINSONS DISEASE, 2016, 2016
  • [43] Neuroprotective Effects of Resveratrol on a Mouse Model of Parkinson's Disease via the Wnt/Beta-Catenin Signaling Pathway
    Qiu, Hancheng
    Dong, Yiying
    Wang, Zhonghai
    Yan, Zhongtian
    Wu, Chunlei
    Yang, Tao
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 (04) : 959 - 968
  • [44] Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson’s Disease
    Sina Shadfar
    Yu-Gyeong Kim
    Nikita Katila
    Sabita Neupane
    Uttam Ojha
    Sunil Bhurtel
    Sunil Srivastav
    Gil-Saeng Jeong
    Pil-Hoon Park
    Jin Tae Hong
    Dong-Young Choi
    Molecular Neurobiology, 2018, 55 : 554 - 566
  • [45] Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease
    Rodriguez-Perez, Ana I.
    Dominguez-Meijide, Antonio
    Lanciego, Jose L.
    Guerra, Maria J.
    Labandeira-Garcia, Jose L.
    NEUROBIOLOGY OF DISEASE, 2013, 58 : 209 - 219
  • [46] Neuroprotective and reparative effects of carotid body grafts in a chronic MPTP model of Parkinson's disease
    Munoz-Manchado, Ana B.
    Villadiego, Javier
    Suarez-Luna, Nela
    Bermejo-Navas, Alfonso
    Garrido-Gil, Pablo
    Labandeira-Garcia, Jose L.
    Echevarria, Miriam
    Lopez-Barneo, Jose
    Toledo-Aral, Juan J.
    NEUROBIOLOGY OF AGING, 2013, 34 (03) : 902 - 915
  • [47] Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease
    Shadfar, Sina
    Kim, Yu-Gyeong
    Katila, Nikita
    Neupane, Sabita
    Ojha, Uttam
    Bhurtel, Sunil
    Srivastav, Sunil
    Jeong, Gil-Saeng
    Park, Pil-Hoon
    Hong, Jin Tae
    Choi, Dong-Young
    MOLECULAR NEUROBIOLOGY, 2018, 55 (01) : 554 - 566
  • [48] Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3
    Guo, Yan-Jie
    Dong, Su-Yan
    Cui, Xin-Xin
    Feng, Ya
    Liu, Te
    Yin, Ming
    Kuo, Sheng-Han
    Tan, Eng-King
    Zhao, Wen-Juan
    Wu, Yun-Cheng
    MOLECULAR NUTRITION & FOOD RESEARCH, 2016, 60 (10) : 2161 - 2175
  • [49] Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease
    Feng, Peng
    Zhang, Xiangjian
    Li, Dongfang
    Ji, Chenhui
    Yuan, Ziyue
    Wang, Ruifang
    Xue, Guofang
    Li, Guanglai
    Holscher, Christian
    NEUROPHARMACOLOGY, 2018, 133 : 385 - 394
  • [50] Resveratrol ameliorates myocardial fibrosis by regulating Sirt1/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy
    Chen, Qingquan
    Zeng, Yu
    Yang, Xiulin
    Wu, Yue
    Zhang, Shuyu
    Huang, Shirong
    Zhong, Yameng
    Chen, Min
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
12345